BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 27145067)

  • 1. Outcomes of liver transplantation with liver grafts from pediatric donors used in adult recipients.
    Croome KP; Lee DD; Burns JM; Saucedo-Crespo H; Perry DK; Nguyen JH; Taner CB;
    Liver Transpl; 2016 Aug; 22(8):1099-106. PubMed ID: 27145067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Donor to Adult Recipients in Donation After Cardiac Death Liver Transplantation: A Single-Center Experience.
    Lan C; Song JL; Yan LN; Yang JY; Wen TF; Li B; Xu MQ
    Transplant Proc; 2017; 49(6):1383-1387. PubMed ID: 28736011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor liver transplantation in patients weighing ≥100 kg: Low graft weight and obesity do not impact outcomes.
    Agarwal S; Goyal N; Nayeem M; Pareek S; Gupta S
    Liver Transpl; 2017 Jan; 23(1):35-42. PubMed ID: 27731927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort.
    Croome KP; Lee DD; Perry DK; Burns JM; Nguyen JH; Keaveny AP; Taner CB
    Liver Transpl; 2017 Mar; 23(3):342-351. PubMed ID: 28027600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octogenarian liver grafts: Is their use for transplant currently justified?
    Jiménez-Romero C; Cambra F; Caso O; Manrique A; Calvo J; Marcacuzco A; Rioja P; Lora D; Justo I
    World J Gastroenterol; 2017 May; 23(17):3099-3110. PubMed ID: 28533667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia.
    Alexopoulos SP; Nekrasov V; Cao S; Groshen S; Kaur N; Genyk YS; Matsuoka L
    Liver Transpl; 2017 Feb; 23(2):221-233. PubMed ID: 27862929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
    Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
    J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.
    Kollmann D; Sapisochin G; Goldaracena N; Hansen BE; Rajakumar R; Selzner N; Bhat M; McCluskey S; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Jun; 24(6):779-789. PubMed ID: 29604237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm results of liver transplantation from donation after circulatory death.
    Blok JJ; Detry O; Putter H; Rogiers X; Porte RJ; van Hoek B; Pirenne J; Metselaar HJ; Lerut JP; Ysebaert DK; Lucidi V; Troisi RI; Samuel U; den Dulk AC; Ringers J; Braat AE;
    Liver Transpl; 2016 Aug; 22(8):1107-14. PubMed ID: 27028896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Portal Inflow Modulation Always Necessary for Successful Utilization of Small Volume Living Donor Liver Grafts?
    Soin AS; Yadav SK; Saha SK; Rastogi A; Bhangui P; Srinivasan T; Saraf N; Choudhary NS; Saigal S; Vohra V
    Liver Transpl; 2019 Dec; 25(12):1811-1821. PubMed ID: 31436885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study.
    Haugen CE; Thomas AG; Garonzik-Wang J; Massie AB; Segev DL
    Transplantation; 2018 Sep; 102(9):1514-1519. PubMed ID: 29570165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric living donor liver transplantation with large-for-size left lateral segment grafts.
    Goldaracena N; Echeverri J; Kehar M; DeAngelis M; Jones N; Ling S; Kamath BM; Avitzur Y; Ng VL; Cattral MS; Grant DR; Ghanekar A
    Am J Transplant; 2020 Feb; 20(2):504-512. PubMed ID: 31550068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right lobe living donors ages 55 years old and older in liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Transpl; 2017 Oct; 23(10):1305-1311. PubMed ID: 28734130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older Donor Age Is a Risk Factor for Negative Outcomes After Adult Living Donor Liver Transplantation Using Small-for-Size Grafts.
    Macshut M; Kaido T; Yao S; Yagi S; Ito T; Kamo N; Nagai K; Sharshar M; Uemoto S
    Liver Transpl; 2019 Oct; 25(10):1524-1532. PubMed ID: 31298473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes Using Grafts from Donors after Cardiac Death.
    Doyle MB; Collins K; Vachharajani N; Lowell JA; Shenoy S; Nalbantoglu I; Byrnes K; Garonzik-Wang J; Wellen J; Lin Y; Chapman WC
    J Am Coll Surg; 2015 Jul; 221(1):142-52. PubMed ID: 26095563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort.
    Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB
    Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.